অনুসন্ধান ফলাফলগুলি - J Louwers
- প্রদর্শন 1 - 2 ফলাফল এর 2
-
1
Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease অনুযায়ী Remi Mahmoud, H. Schultheiss, J Louwers, Michiel van der Kaaij, B van Hellemondt, Nofel Mahmmod, P van Boeckel, Bindia Jharap, Herma H. Fidder, Bas Oldenburg
প্রকাশিত 2022Artigo -
2
Loss of response to anti‐TNFα agents depends on treatment duration in patients with inflammatory bowel disease অনুযায়ী J Schultheiss, Remi Mahmoud, J Louwers, Michiel T. van der Kaaij, Boris P. van Hellemondt, Petra G. Van Boeckel, Nofel Mahmmod, Bindia Jharap, Herma H. Fidder, Bas Oldenburg
প্রকাশিত 2021Artigo
অনুসন্ধান সাধনীগুলি:
সম্পর্কিত বিষয়
Confidence interval
Discontinuation
Disease
Gastroenterology
Hazard ratio
Inflammatory bowel disease
Infliximab
Internal medicine
Medicine
Proportional hazards model
Retrospective cohort study
Adalimumab
Cohort
Concomitant
Crohn's disease
Incidence (geometry)
Interquartile range
Odds ratio
Optics
Physics
Rheumatoid arthritis
Surgery
Tacrolimus
Transplantation
Trough level
Tumor necrosis factor alpha
Ulcerative colitis